A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment
N/A
Study to collect the data on Chronic Obstructive Pulmonary Disease (COPD) p...
Status
Completed
Location
Ditmanson Medical Foundation Chia - Yi Christian Hospital
A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)
N/A
This study looks at data from people with chronic obstructive pulmonary dis...
Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)
PHASE2
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.9.00152 Boehringer Ingelheim Investigational Site
A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
PHASE4
To demonstrate the efficacy of inhaled tiotropium + olodaterol via Respimat...
Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma
PHASE3
The aim of this trial is to evaluate the safety and efficacy of 2.5 and 5 µ...
Status
Completed
Location
205.464.81020 Boehringer Ingelheim Investigational Site
Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers
PHASE1
Study to investigate safety and tolerability of single, inhaled doses (2.5 ...
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.
PHASE3
The overall objective is to assess the effect of once daily tiotropium + ol...
Status
Completed
Location
1237.19.10039 Boehringer Ingelheim Investigational Site